BioSpace News Archive

Express Scripts Holding Company announced consolidated 2018 third quarter net income of $1,071.6 million or $1.89 per diluted share.

SILVER SPRING, Md., /PRNewswire/ -- Today, the U.S. Food and Drug Administration permitted marketing, with special controls, of the 23andme Personal Genome Service Pharmacogenetic Reports test as a direct-to-consumer test for providing information about genetic variants that may be associated with a patient’s ability to metabolize some medications to help inform discussions with a health care provider.

Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, today announced that Melvin K. Spigelman, M.D., who has served as an Independent Director of Synergy since August 2008, will now assume the role of Chairman of the Board, effective immediately.

CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today its financial results for the third quarter ended September 30, 2018.

San Diego Personal Injury Lawyer Robert Vaage wins over $3 million in damages from Kaiser for his client, who was rendered a partial paraplegic as a result of the Kaiser system’s negligence.

Brookdale Senior Living Inc. today announced that Lucinda “Cindy” Baier, President and Chief Executive Officer will participate in a discussion regarding the Company at the Stephens NY Investment Conference in New York, New York on Wednesday, November 7, 2018, beginning at 7:30 a.m. Eastern Time.

Akoya Biosciences has acquired PerkinElmer, Inc.’s Phenoptics™ portfolio.

GeneQuantum Healthcare and Biocytogen reached a Strategic Cooperation Agreement focusing on the development of next generation bioconjugates for tumor immunotherapy in Beijing on October 29, 2018.

The decision allows 23andMe to report directly to customers, without a prescription, the influence their genetics have on how well they metabolize certain medications

Celprogen Inc. today announced that they have successfully finished printing 3D Brains from brain stem cells for studying neurological disease stages.